HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Treatment of Hypertrophic Burn and Traumatic Scars With a 2,940-nm Fractional Ablative Erbium-doped Yttrium Aluminium Garnet Laser: A Pilot Study.

AbstractBACKGROUND:
In recent years, fractional ablative lasers at low density have proven to be the centerpiece in a multimodality approach to treating hypertrophic burn scars.
OBJECTIVE:
To determine the safety and efficacy of fractional ablative erbium-doped yttrium aluminium garnet (Er:YAG) laser in the treatment of hypertrophic burn scars.
METHODS:
Eleven patients received 3 fractional ablative Er:YAG laser to hypertrophic burn scars at 400 to 800 μm, density 11%, no coagulation, and single pass at 4-week intervals.
RESULTS:
Overall, average improvement was noted to be 2.27 of 3 as determined by blinded observers. A significant improvement was noted in all measured parameters including dyschromia, atrophy hypertrophy, vascularity, and texture.
CONCLUSION:
This is a pilot study showing the safety and efficacy of fractional ablative Er:YAG laser treatment is a safe and effective treatment modality in the treatment of hypertrophic scars.
AuthorsAdam J Wulkan, Ashley Rudnick, Evangelos Badiavas, Jill S Waibel
JournalDermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.] (Dermatol Surg) Vol. 46 Issue 6 Pg. 789-793 (06 2020) ISSN: 1524-4725 [Electronic] United States
PMID31876571 (Publication Type: Journal Article)
Topics
  • Adolescent
  • Adult
  • Aged
  • Burns (complications, surgery)
  • Cicatrix, Hypertrophic (diagnosis, etiology, surgery)
  • Female
  • Humans
  • Laser Therapy (adverse effects, instrumentation, methods)
  • Lasers, Solid-State (therapeutic use)
  • Male
  • Middle Aged
  • Patient Satisfaction
  • Pilot Projects
  • Prospective Studies
  • Treatment Outcome
  • Young Adult

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: